Cargando…
Bivariate network meta‐analysis for surrogate endpoint evaluation
Surrogate endpoints are very important in regulatory decision making in healthcare, in particular if they can be measured early compared to the long‐term final clinical outcome and act as good predictors of clinical benefit. Bivariate meta‐analysis methods can be used to evaluate surrogate endpoints...
Autores principales: | Bujkiewicz, Sylwia, Jackson, Dan, Thompson, John R., Turner, Rebecca M., Städler, Nicolas, Abrams, Keith R., White, Ian R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618064/ https://www.ncbi.nlm.nih.gov/pubmed/31131475 http://dx.doi.org/10.1002/sim.8187 |
Ejemplares similares
-
Use of copula to model within‐study association in bivariate meta‐analysis of binomial data at the aggregate level: A Bayesian approach and application to surrogate endpoint evaluation
por: Papanikos, Tasos, et al.
Publicado: (2022) -
Uncertainty in the Bayesian meta-analysis of normally distributed surrogate endpoints
por: Bujkiewicz, Sylwia, et al.
Publicado: (2015) -
Bayesian meta‐analytical methods to incorporate multiple surrogate endpoints in drug development process
por: Bujkiewicz, Sylwia, et al.
Publicado: (2015) -
Bayesian hierarchical meta‐analytic methods for modeling surrogate relationships that vary across treatment classes using aggregate data
por: Papanikos, Tasos, et al.
Publicado: (2020) -
Using Bayesian Evidence Synthesis Methods to Incorporate Real-World Evidence in Surrogate Endpoint Evaluation
por: Wheaton, Lorna, et al.
Publicado: (2023)